Related content

The impact of smoking on pathologic response to neoadjuvant cisplatin-based chemotherapy in patients with muscle-invasive bladder cancer

By Kim Philip   Kent Matthew   Zhao Philip   Sfakianos John   Bajorin Dean   Bochner Bernard   Dalbagni Guido  

World Journal of Urology, Vol. 32, Iss. 2, 2014-04 ,pp. : 453-459

Springer Publishing Company

Access to resources Recommend Favorite

The Predictive Value of Sentinel Lymph Node Biopsy in Locally Advanced Breast Cancer Patients Who Have Undergone Neoadjuvant Chemotherapy

By Yamamoto Maki   Mehta Rita S.   Baick Choong H.   Su Min-Ying   Lane Karen T.   Butler John A.   Hsiang David J.  

The American Surgeon, Vol. 73, Iss. 10, 2007-10 ,pp. : 977-980

Southeastern Surgical Congress

Access to resources Recommend Favorite

Evaluation of the Renal Function Using Cystatin C Level in the Patients Receiving Cisplatin-Based Chemotherapy

By Kos F.T.  

Renal Failure, Vol. 35, Iss. 5, 2013-06 ,pp. : 705-710

Informa Healthcare

Access to resources Recommend Favorite

The role of rescue radical cystectomy (RCT) in a bladder preservation program based on tur plus chemotherapy for patients with invasive blaader cancer

By Solsona E.   Iborra I.   Ricos J.V.   Monros J.L.   Dumont R.   Rubio J.   Casanova J.L.  

European Urology Supplements, Vol. 2, Iss. 1, 2003-02 ,pp. : 128-128

Elsevier

Access to resources Recommend Favorite

Young Women with Locally Advanced Breast Cancer Who Achieve Breast Conservation after Neoadjuvant Chemotherapy Have a Low Local Recurrence Rate

By Sweeting Raeshell S.   Klauber-DeMore Nancy   Meyers Michael O.   Deal Allison M.   Burrows Emily M.   Drobish Amy A.   Anders Carey K.   Carey Lisa A.  

The American Surgeon, Vol. 77, Iss. 7, 2011-07 ,pp. : 850-855

Southeastern Surgical Congress

Access to resources Recommend Favorite